A comprehensive study of polymorphisms inABCB1, ABCC2andABCG2and lung cancer chemotherapy response and prognosis

Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients

(2010) Z. Sun et al.   ANNALS OF ONCOLOGY

MDR1 C2005T polymorphism changes substrate specificity

(2010) Lijuan Liu et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Significant Effect of Polymorphisms inCYP2D6andABCC2on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients

(2010) Kazuma Kiyotani et al.   JOURNAL OF CLINICAL ONCOLOGY

P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 Determine the Pharmacokinetics of Etoposide

(2009) J. S. Lagas et al.   CLINICAL CANCER RESEARCH

Pharmacogenetics of Membrane Transporters: An Update on Current Approaches

(2009) Tristan M. Sissung et al.   MOLECULAR BIOTECHNOLOGY

Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia

(2008) Kazuma Kiyotani et al.   CANCER SCIENCE

A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms

(2008) Xiaoyi Gao et al.   GENETIC EPIDEMIOLOGY

Polymorphisms inABCG2,ABCC3andCNT1genes and their possible impact on chemotherapy outcome of lung cancer patients

(2008) Phillip J. Müller et al.   INTERNATIONAL JOURNAL OF CANCER

Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol

(2008) Sierk Haenisch et al.   Pharmacogenetics and Genomics